Filing Flows › Health Care › LifeStance Health Group (LFST)
LifeStance Health Group (LFST) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 5, 2026 · LifeStance Health Group (LFST) Q3 2026 earnings results →
Q3 2026 Revenue up 25% year over year to $456M · 5¢ of every $1 of revenue kept as net profit · operating margin 7.3%
LifeStance Health Group made $456M in Q3 2026 (+25% Y/Y). Operating margin 7.3%, net earnings $22.4M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 5, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $455.9M in Q3 2026, up 25% year over year and up 5% from the previous quarter.
Operating profit was $33.1M, a 7.3% margin (up 5.2 points year over year). Of the extra revenue versus Q3 2025, 28% reached operating profit, above the 2% margin then. Total costs grew 19% against revenue growth of 25%. The fastest-growing cost line was Other operating costs (+19%). Net earnings were $22.4M, up 1978% year over year. The effective tax rate was 18.3%.
Operating cash flow was $37.0M (up 36% year over year), 165% of net earnings. Non-cash charges added back $12.1M of depreciation and amortization and $18.2M of share-based compensation. Working capital and other items used $15.6M. Capital expenditures of $14.7M left free cash flow of $22.4M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 5, 2026 | $456M | +25% | 7.3% | $22.4M | $37.0M |
| Q2 2026 | 10-Q | Aug 6, 2026 | $435M | +26% | 7.0% | $23.6M | $99.9M |
| Q1 2026 | 10-Q | May 7, 2026 | $403M | +21% | 5.5% | $14.2M | $33.1M |
| Q4 2025 | 10-K | Feb 25, 2026 | $382M | +17% | 4.7% | $11.7M | $57.6M |
| Q3 2025 | 10-Q | Nov 6, 2025 | $364M | +16% | 2.0% | $1.1M | $27.3M |
| Q2 2025 | 10-Q | Aug 7, 2025 | $345M | +11% | -0.9% | −$3.8M | $64.4M |
| Q1 2025 | 10-Q | May 7, 2025 | $333M | +11% | 0.5% | $709K | −$3.1M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About LifeStance Health Group
Founded in 2017, LifeStance (Nasdaq: LFST) is reimagining mental health. We are one of the nation’s largest providers of virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Our mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable, and personalized mental healthcare. LifeStance and its supported practices employ over 8,500 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers. To learn more, please visit www.LifeStance.com.
In its own words, from its 8-K, filed Aug 6, 2026.
LifeStance Health Group against its Services-Health Services peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +25% against the peers' median +13%. Operating margin: 7.3% against the peers' median 5.5%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| LFST LifeStance Health Group | Q3 2026 | $456M | +25% | 7.3% |
| PRVA Privia Health Group | Q3 2026 | $657M | +13% | 3.1% |
| PIII P3 Health Partners | Q2 2026 | $386M | +9% | 10.7% |
| PNTG Pennant Group | Q3 2026 | $302M | +32% | 5.5% |
| INNV InnovAge Holding | Q1 FY27 | $265M | +12% | 7.6% |
| USPH U S Physical Therapy | Q3 2026 | $223M | +13% | 11.3% |
| WGS GeneDx Holdings | Q2 2026 | $114M | +11% | -15.3% |
| OMDA Omada Health | Q3 2026 | $91.3M | +34% | 5.3% |
| DCGO DocGo | Q2 2026 | $73.4M | -9% | -24.4% |
Source: LifeStance Health Group 10-Q on SEC EDGAR · CIK 1845257 · Services-Health Services
Guidance and outlook
13F: who owns LFST and who is buying
More on LFST
- How LifeStance Health Group makes money: revenue by segment
- LifeStance Health Group next earnings date and what analysts expect
- LifeStance Health Group stock forecast, price target and fair value
- Who owns LifeStance Health Group stock: holders, funds and Congress trades
- LifeStance Health Group guidance and outlook
- Is LifeStance Health Group a takeover target? LBO and rumors
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results